Europe Drug Delivery Devices Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Drug delivery is the technology utilised to present the drug to the desired body site for drug release and absorption, or the subsequent transport of the active ingredients across the biological membranes to the site of action. A drug delivery system is a device that facilitates the introduction of a therapeutic substance in the body and improves its performance and safety by controlling the rate, time and place of release of drugs in the body.

Europe Drug Delivery Devices Market Report Segments Size & Growth:

Europe drug delivery devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include technological advancements, increased prevalence of chronic diseases, need for controlled drug release, the rise in individual therapy, and increased understanding about drug metabolism among the population. However, recall of the products, strict regulatory framework, and injuries and infections fear while usage is thereby hindering the market growth. Various opportunities for drug delivery devices market include increasing demand for biosimilars and generic drugs, focus on overcoming unmet medical needs, self-administration & home care, and emerging markets.

Europe Drug Delivery Devices Market Report Segments Share:

Europe drug delivery devices market is categorised into the mode of delivery which comprises of nasal, oral, ocular, implantable, injectable, transdermal, topical, pulmonary, rectal, and other. Furthermore, they are categorised into various sub-segments. By nasal, it is segmented into nasal inhalers, nasal sprays, nasal drops, and others. By oral, it is segmented into hydrodynamic pressure controlled system, slow dissolving salts & complexes, ion – exchange resin drug complexes, Ph – independent formulations, osmotic pressure controlled systems, diffusion controlled systems, and dissolution controlled systems. By ocular, it is segmented into ointments & gels, eye drops, and others. By implantable, it is segmented into intravitreal implants, brachytherapy seeds, contraceptives, and drug-eluting stents. By injectable, it is segmented into conventional drug delivery and self-Injected drug delivery. By transdermal, it is segmented into the mode of administration, type of patches, & transdermal gels and they are further segmented into microscopic injections, ultrasound, electroporation, iontophoresis, vapour patch, matrix, reservoir, multilayer drug in adhesive, single layer drug in the adhesive. By topical, it is segmented into semi-solid formulations, liquid formulations, and solid formulations. By pulmonary, it is segmented into the nebuliser, dry powder inhalers, and metered dose inhalers. The topical segment is anticipated to witness the highest growth rate. The factors which the boosting the growth of the segment are convenience and ease of use, ease of dosage, painlessness, noninvasiveness, and enhanced patient compliance.

By end-users, the market is segmented into hospitals, ambulatory surgical centres/clinics, home care settings, diagnostic centres, and others. Among them, the hospital’s segment is expected to hold the largest share in the market during the forecast period owing to increasing number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to procure to the demand of the patient pool.

By Geography, UK is expected to hold the largest share in the market because of the increasing demand for improved drug delivery systems, rising accessibility and affordability of drug delivery devices, and increasing number of chronic diseases in the region. France is expected to witness the highest growth rate because of rising prevalence of various chronic diseases and ageing population in this region. Furthermore, the improving economic conditions in the region are also expected to support the growth of the drug delivery devices market in Europe.

Europe Drug Delivery Devices Market Report Trends:

• Baxter International and Scinopharm have announced a strategic partnership to develop, manufacture, and commercialise an initial five oncology drugs, with scope for an additional 15 injectable molecules.
• 3M company and impel neuropharma Inc has announced a strategic alliance aimed at advancing Impel’s revolutionary precision olfactory delivery (POD) technology for the enhanced central nervous system (CNS) delivery of drug products.

Europe Drug Delivery Devices Market Report Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• Abbott Laboratories
• Braun Melsungen AG
• Pfizer, Inc.
• Hoffmann-La Roche Ltd.
• Baxter International Inc.

Along with these companies, there were many other companies considered/cited in the report while analysing the Europe drug delivery devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach, and strong custom.